Skip to content

Clinical trials

Terminated Diabetes Mellitus, Type 2 trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Status: Terminated Country / region: Australia Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20053
20061
20074
20082
20092
20102
20124
20131
20142
20171
20182

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated26

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca6
Eli Lilly and Company3
Lexicon Pharmaceuticals3
Takeda3
Bayside Health2
DiObex2
Novo Nordisk A/S2
GlaxoSmithKline1
NephroGenex, Inc.1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 226
Diabetes Mellitus6
Diabetes Mellitus, Type 12
Diabetic Nephropathies2
Heart Failure2
Renal Insufficiency, Chronic2
Asthma1
Cardiovascular Diseases1
Heart Diseases1
Kidney Diseases1

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.